Abstract Coronavirus disease 2019 (COVID-19) is a major threat worldwide due to its fast
spreading. As yet, there are no established drugs available. Speeding up drug discovery is …

Background: Coronavirus Disease 2019 (COVID-19) pandemic continues to threaten
patients, societies and healthcare systems around the world. There is an urgent need to …

With the rapidly evolving SARS-CoV-2 variants of concern, there is an urgent need for the
discovery of further treatments for the coronavirus disease (COVID-19). Drug repurposing is …

The main protease (Mpro) of the SARS‐CoV‐2 has been proposed as one of the major drug
targets for COVID‐19. We have identified the experimental data on the inhibitory activity of …

In December 2019, an infectious disease caused by the coronavirus SARS‐CoV‐2
appeared in Wuhan, China. This disease (COVID‐19) spread rapidly worldwide, and on …

A novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), or
2019 novel coronavirus] has been identified as the pathogen of coronavirus disease 2019 …

SARS-CoV-2 has caused tens of thousands of infections and more than one thousand
deaths. There are currently no registered therapies for treating coronavirus infections …

The global pandemic of coronavirus disease 2019 (COVID-19), caused by novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …

The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) requires treatments with rapid clinical translatability. Here we develop a multi-target …

Severe Acute Respiratory Syndrome Corona Virus 2 has altered life on a global scale. A
concerted effort from research labs around the world resulted in the identification of potential …